Key facts
- In November 2024, 249 cases were reported by 11 countries. Thirteen countries reported zero cases.
- Through its epidemic intelligence activities, ECDC identified an additional 68 new cases from eight EU countries.
- In 2024,19 measles-related deaths have been reported in Romania (18) and Ireland (1).
- There has been high measles activity overall in the EU/EEA over the last 12 months; however, the situation varies by country. Some countries have reported large and/or ongoing outbreaks while others have reported no sustained or very low transmission.
- An update for select countries outside of the EU/EEA is provided (Morocco).
Overview
In November 2024, 249 measles cases were reported by 11 countries and zero cases by 13 countries. In the most recent 12-month period, from 1 December 2023 to 30 November 2024, 30 EU/EEA countries reported a total of 17 329 cases of measles. Between 1 December 2023 and 30 November 2024, of the 17 329 cases with known age, 7 598 (43.8%) cases were in children under five years old and 5 081 (29.3%) cases were in individuals 15 years old or above.
The highest notification rates were observed in infants under one year old (550.3 cases per million population) and children aged 1–4 years old (321.6 cases per million population). Of 14 364 cases (100.0% of all cases) with a known age and vaccination status, 12 522 (87.2%) were unvaccinated, 1 200 (8.4%) were vaccinated with one dose of a measles-containing vaccine, 600 (4.2%) were vaccinated with two or more doses, and 25 (0.2%) were vaccinated with an unknown number of doses. Thirteen deaths (case fatality rate (CFR): 0.1) attributable to measles were reported to ECDC during the 12-month period by Romania (12) and Ireland (1). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.
Complementary epidemic intelligence surveillance, with data collection conducted on 9 January 2025 from official public sources, identified 68 new measles cases reported since the last monthly update. New cases were reported in eight EU countries: Austria (new: 20; total: 529), Czechia (new: 1; total: 35), Germany (new: 10; total: 646), Hungary (new: 1; total: 32), Ireland (new: 31; total: 213), the Netherlands (new: 3; total: 190); Norway (new: 1; total: 10) and Sweden (new: 1; total: 38). No measles-related deaths have been reported in recent months. Overall, 19 measles-related deaths have been reported in the EU/EEA in 2024, in Romania (18) and in Ireland (1).
Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy and EpiPulse Cases. Data presented in the two monthly reports may differ.
Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:
Since the last monthly update, new measles cases were reported in the following countries.
Austria reported 529 confirmed measles cases since 1 January 2024 and as of 2 January 2025, an increase of 20 cases since 3 December 2024. On 3 January 2025, the Gmunden district administration reported a measles case in Gosau in Dachstein West ski region to inform that further infections may be associated with this exposure.
Czechia reported one measles case in December 2024, and as of 1 January 2025, 35 measles cases have been reported in 2024.
Finland reported no new measles cases since the last monthly update and as of 9 January 2025. On 9 January 2025, the National Institute for Health and Welfare (THL) reported that an individual infected with measles travelled on a ferry from Tallinn to Helsinki on 7 January. The risk of infection for other passengers was assessed as "very small".
Germany reported 646 measles cases, an increase of 10 cases since the last monthly report. Of these, 645 measles cases were reported in 2024 and one in 2025 (data as of 9 January 2025).
Hungary reported 32 measles cases as of 6 January 2024, an increase of one case since 1 December 2024.
Ireland reported 29 measles cases between weeks 47–52, 2024 and a total of 213 measles cases in 2024. Two measles cases were reported in week 1, 2025 (data as of 4 January 2025).
Netherlands reported 190 measles cases in 2024 up to and including 16 December, of which three cases were reported in December 2024.
Norway reported 10 measles cases in 2024 and one case in 2025 (data as of 9 January 2025).
Sweden reported 38 cases in 2024 and as of 9 January 2025. Of these, one case was reported in December 2024.
Epidemiological summary for select countries outside of EU/EEA with relevant epidemic intelligence updates:
Morocco
According to media reports (1,2), on 30 December 2024 the Moroccan health authorities provided an update on the ongoing nationwide measles epidemic in Morocco. The outbreak began in the Souss-Massa region in October 2023 and has since spread nationwide.
Since October 2023, 19 515 cases have been reported, with an incidence rate of 52.5 cases per 100 000 population. The authorities have reported 107 deaths due to measles (0.55% of the reported cases), of which approximately half were in children under 12 years old.
In 2024 alone, authorities reported 17 999 measles cases (5 094 confirmed) and 104 deaths.
The increase in measles cases is attributed to declining vaccination rates following the COVID-19 pandemic and vaccine hesitancy. However, according to the WHO data, between 2016 and 2023 Morocco reported 99% coverage of the first and second doses of measles vaccine.
Summary of measles cases reported by WHO regional offices
*As of 10 January 2025, the latest available measles data from WHO is from 11 December 2024. This data was reported in the ECDC monthly measles update in December 2024.
WHO Regional Office for Europe (WHO/Europe) reported 104 849 measles cases in 2024. The five non-EU/EEA countries reporting the most measles cases were: Kazakhstan (27 967), Russian Federation (21 249), Azerbaijan (16 685), Kyrgyzstan (13 050) and the United Kingdom (2 756).
The numbers provided to WHO for EU/EEA countries are from TESSy data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.
WHO Regional Office for Africa (WHO AFRO) has reported 80 769 measles cases in 2024. The highest numbers of cases were reported from Ethiopia (28 139), Nigeria (10 237), Burkina Faso (7 147), Cote d’Ivoire (6 464) and the Democratic Republic of the Congo (4 489).
WHO Regional Office for the Americas (WHO PAHO) has reported 436 measles cases in 2024. Most cases (280) were reported from the United States.
WHO Regional Office for the Eastern Mediterranean (WHO EMRO) has reported 88 751 measles cases in 2024. The highest numbers of cases were reported from Iraq (32 179), Pakistan (23 596), Yemen (19 988), Afghanistan (8 816) and Somalia (1 306).
WHO Regional Office for South-East Asia (WHO SEARO) has reported 32 838 measles cases in 2024. The highest numbers of cases were reported from India (19 852), Thailand (7 507), Indonesia (4 718), Sri Lanka (296), and Nepal (222).
WHO Regional Office for the Western Pacific (WHO WPRO) has reported 9 207 measles cases in 2024. The following five countries reported the most cases: the Philippines (3 686), Malaysia (3 574), China (939), Viet Nam (852), and the Republic of Korea (47).
ECDC assessment
The overall number of measles cases in the EU/EEA steadily increased between June 2023 and March 2024 and decreased between April 2024 and October 2024. In November 2024, a slight increase in case numbers compared with October 2024 was observed. Measles cases may continue to increase in the EU/EEA in the coming months. This is due to reported suboptimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries (<95% in many of these countries), as well as a high probability of importation from areas experiencing high circulation. In addition, the majority of recently reported cases have acquired the disease within the reported country through community/local transmission, indicating a higher probability of being exposed to the virus within the EU/EEA than in previous months.
As the number of cases is expected to rise in the near future, ECDC urges EU/EEA public health authorities to focus on the following areas:
- Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
- Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
- Increase the clinical awareness of health professionals.
- Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
- Address barriers and engage with underserved populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions of that remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.
Actions
ECDC is monitoring the measles situation through its epidemic intelligence activities, which supplement monthly outputs with measles surveillance data from TESSy, routinely submitted by 30 EU/EEA countries. ECDC's latest advice on measles is available in the Threat Assessment Brief, 'Measles on the rise in the EU/EEA: Considerations for a public health response', published on 15 February 2024.